These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2538674)

  • 1. Simultaneous presence of platelet activating factor, leukotriene B4, prostaglandin F1 alpha and F2 alpha in the supernatant of human neutrophils treated with phospholipase A2 of human monocytes.
    Sipka S; Dinya Z; Gergely P; Farkas T; Szegedi G
    Klin Wochenschr; 1989 Feb; 67(3):123-5. PubMed ID: 2538674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase A2 of human monocytes with molecular weight of 73 kD induces the production of prostaglandin derivatives and leukotriene B4 in the suspension of human neutrophil granulocytes.
    Sipka S; Gergely P; Farkas T; Dinya Z; Szegedi G
    Acta Paediatr Hung; 1988-1989; 29(1-2):51-3. PubMed ID: 2855607
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor necrosis factor stimulates human neutrophils to release leukotriene B4 and platelet-activating factor. Induction of phospholipase A2 and acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine O2-acetyltransferase activity and inhibition by antiproteinase.
    Camussi G; Tetta C; Bussolino F; Baglioni C
    Eur J Biochem; 1989 Jul; 182(3):661-6. PubMed ID: 2546764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models.
    Burke JR; Davern LB; Stanley PL; Gregor KR; Banville J; Remillard R; Russell JW; Brassil PJ; Witmer MR; Johnson G; Tredup JA; Tramposch KM
    J Pharmacol Exp Ther; 2001 Jul; 298(1):376-85. PubMed ID: 11408565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of type II phospholipase A2 and platelet-activating factor on Mac-1 surface expression and exocytosis of gelatinase granules in human neutrophils: evidence for the 5-lipoxygenase-dependent mechanism.
    Takasaki J; Kawauchi Y; Masuho Y
    J Immunol; 1998 May; 160(10):5066-72. PubMed ID: 9590257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligomers of prostaglandin B1 inhibit arachidonic acid mobilization in human neutrophils and endothelial cells.
    Rosenthal MD; Franson RC
    Biochim Biophys Acta; 1989 Dec; 1006(3):278-86. PubMed ID: 2557075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'.
    Fradin A; Rothhut B; Poincelot-Canton B; Errasfa M; Russo-Marie F
    Biochim Biophys Acta; 1988 Nov; 963(2):248-57. PubMed ID: 2848583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BIRM 270: a novel inhibitor of arachidonate release that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils.
    Farina PR; Graham AG; Hoffman AF; Watrous JM; Borgeat P; Nadeau M; Hansen G; Dinallo RM; Adams J; Miao CK
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1418-26. PubMed ID: 7996454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity.
    Rubin BB; Downey GP; Koh A; Degousee N; Ghomashchi F; Nallan L; Stefanski E; Harkin DW; Sun C; Smart BP; Lindsay TF; Cherepanov V; Vachon E; Kelvin D; Sadilek M; Brown GE; Yaffe MB; Plumb J; Grinstein S; Glogauer M; Gelb MH
    J Biol Chem; 2005 Mar; 280(9):7519-29. PubMed ID: 15475363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
    Bauldry SA; Wooten RE
    Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group IB secretory phospholipase A2 stimulates leukotriene B4 production by a unique mechanism in human neutrophils.
    Lee HY; Kim MK; Park KS; Shin EH; Bae YS
    Biochem Biophys Res Commun; 2005 Aug; 334(2):500-8. PubMed ID: 16005851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the predominant role of intracellular PAF binding sites in the regulation of phospholipase A2 in human neutrophils.
    Nigam S; Eskafi S; Müller S; Zhang H
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():471-3. PubMed ID: 7732894
    [No Abstract]   [Full Text] [Related]  

  • 13. Phospholipase A2 as leukotriene B4 secretagogue for human polymorphonuclear leukocytes.
    Lam BK; Yang CY; Wong PY
    Adv Exp Med Biol; 1990; 275():183-91. PubMed ID: 2173367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction by chemokines of lipid mediator synthesis in granulocyte-macrophage colony-stimulating factor-treated human neutrophils.
    McDonald PP; Pouliot M; Borgeat P; McColl SR
    J Immunol; 1993 Dec; 151(11):6399-409. PubMed ID: 8245474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.
    Marshall LA; Hall RH; Winkler JD; Badger A; Bolognese B; Roshak A; Flamberg PL; Sung CM; Chabot-Fletcher M; Adams JL
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1254-62. PubMed ID: 7562496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene B4 stimulates phospholipase-C-mediated formation of inositol trisphosphate in neutrophils: implications for convergence of the phospholipase A2 and C pathways.
    Bradford PG; Rubin RP
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():105-8. PubMed ID: 3004128
    [No Abstract]   [Full Text] [Related]  

  • 17. Phospholipase A2 modulation by calmodulin, prostaglandins and cyclic nucleotides.
    Moskowitz N; Shapiro L; Schook W; Puszkin S
    Biochem Biophys Res Commun; 1983 Aug; 115(1):94-9. PubMed ID: 6311214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase A2 activation in human neutrophils requires influx of extracellular Ca2+ and leukotriene B4.
    Reddy S; Bose R; Rao GH; Murthy M
    Am J Physiol; 1995 Jan; 268(1 Pt 1):C138-46. PubMed ID: 7840141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock.
    Nakae H; Endo S; Inada K; Yaegashi Y; Takakuwa T; Yamada Y; Arakawa N; Suzuki T; Taniguchi S; Shimamura T; Ogawa M; Teraoka H
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):131-9. PubMed ID: 8774066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 limits arachidonic acid availability and inhibits leukotriene B4 synthesis in rat alveolar macrophages by a nonphospholipase A2 mechanism.
    Christman BW; Christman JW; Dworski R; Blair IA; Prakash C
    J Immunol; 1993 Aug; 151(4):2096-104. PubMed ID: 8393898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.